The Advancement of Stem Cell Technology Irvine Stem Cell Treatment Center

Welcome to the Irvine Stem Cell Treatment Center, an affiliate of the Miami Stem Cell Treatment Center (www.MiamiStemCellsUSA.com) and the Manhattan Regenerative Medicine Medical Group (www.NYStemCellsUSA.com)

Our affiliated Centers utilize cutting edge advanced techniques and innovative technology to improve the health and well being of our patients.

At the Irvine Stem Cell Treatment Center, we engage in the investigational use of Adult Autologous Adipose Derived Stem Cells (ADSC’s) for clinical research and deployment – through which patients who are suffering from diseases that may have limited treatment options have an opportunity to respond to stem cell based regenerative medicine – and further advance the state of medicine, knowledge, and options for all patients.

Our expertise involves a deep commitment and long-term understanding, knowledge and experience in clinical research and the advancement of regenerative medicine. Our staff and Physicians at the Irvine Stem Cell Treatment Center have been specially trained in the technology and methodology of the harvesting, processing and deployment of autologous (your own) Adult Autologous Adipose-derived Stem Cells (ADSC’s) and in providing investigational therapy to patients with various inflammatory and/or degenerative conditions.

Our Centers utilize a fat transfer technology to isolate and implant the patient’s own Adult Autologous Adipose-derived Stem Cells (ADSC’s) from a small quantity of fat harvested by mini-liposuction on the same day. Our technology was developed in the United States and uses the highest technological methods which produces a cellular medium called “Stromal Vascular Fraction” (SVF) which is rich in progenitor and Stem Cells. We do NOT utilize the addition of chemicals or enzymes to produce the SVF, but rather remain consistent with all F.D.A. Guidance relating to stem cell therapy.

Our Protocols are approved by an IRB (Institutional Review Board), and accordingly we are able to safely provide adipose (fat)-derived stem cell procedures on an investigational basis to our patients. The approving IRB is registered with the U.S. Department of Health, Office of Human Research Protection (OHRP) – AND – United States F.D.A​. We have assembled a multidisciplinary team to assist evaluate patients with a variety of conditions which are known to often be responsive to Stem Cell therapy.

All our affiliate members, including our Irvine Stem Cell Treatment Center, contribute to the collection of our Center’s IRB approved investigational data. In this manner, we are continuously updating, researching, and learning more on how to help patients and advance the state of the art of regenerative medicine.

All patients who are interested in our investigational protocols will be evaluated by our physicians – specially trained in our adipose-derived stem cell procedures – and given an honest opinion as to the potential benefits and risks of stem cell therapy for their presenting condition.

Medical Conditions

Irvine Stem Cell Treatment Center

The Irvine Stem Cell Treatment Center is proud to be part of an Institutional Review Board (IRB)-based stem cell procedure network in the United States which utilizes fat-transfer surgical technology. We an array of ongoing IRB-approved protocols, and we provide care for patients with a wide variety of disorders that may benefit from adult stem cell-based regenerative therapy. At the Irvine Stem Cell Treatment Center we exploit anti-inflammatory, immuno-modulatory and regenerative properties of Adult Autologous Adipose-derived Stem Cells (ADSC’s) to mitigate inflammatory and degenerative diseases.

At the Irvine Stem Cell Treatment Center we provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative medicine. Our Center utilizes a fat-transfer surgical technology to isolate and implant the patient’s own Adult Autologous Adipose-derived Stem Cells from a small quantity of fat harvested by a mini-liposuction on the same day.  Please review our Medical Conditions for more information.

Dr. Thomas A. Gionis, MD JD
Surgeon-in-Chief,
Medical Director
Stem Cell Research and Treatment